Literature DB >> 9662688

Overtraining and immune system: a prospective longitudinal study in endurance athletes.

H H Gabriel1, A Urhausen, G Valet, U Heidelbach, W Kindermann.   

Abstract

A prospective longitudinal study investigated for 19 +/- 3) months whether immunophenotypes of peripheral leukocytes were altered in periods of severe training. Leukocyte membrane antigens (CD3, CD4, CD8, CD14, CD16, CD19, CD45, CD45RO, and CD56) of endurance athletes were immunophenotyped (dual-color flow cytometry) and list mode data analyzed by a self-learning classification system in a state of an overtraining syndrome (OT; N = 15) and several occasions without symptoms of staleness (NS; N = 70). Neither at physical rest nor after a short-term highly intensive cycle ergometer exercise session at 110% of the individual anaerobic threshold did cell counts of neutrophils, T, B, and natural killer cells differ between OT and NS. Eosinophils were lower during OT, activated T cells (CD3+HLA/DR+) showed slight increases (NS: 5.5 +/- 2.7; OT 7.3 +/- 2.4% CD3+ of cells; means +/- SD; P < 0.01) during OT without reaching pathological ranges. The cell-surface expression of CD45RO (P < 0.001) on T cells, but not cell concentrations of CD45RO+ T cells, were higher during OT. OT could be classified with high specificities (92%) and sensitivities (93%). It is concluded that OT does not lead to clinically relevant alterations of immunophenotypes in peripheral blood and especially that an immunosuppressive effect cannot be detected. Immunophenotyping may provide help with the diagnosis of OT in future, but the diagnostic approach presented here requires improvements before use in sports medicine practice is enabled.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9662688     DOI: 10.1097/00005768-199807000-00021

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  14 in total

Review 1.  The unknown mechanism of the overtraining syndrome: clues from depression and psychoneuroimmunology.

Authors:  Lawrence E Armstrong; Jaci L VanHeest
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 2.  Biochemical aspects of overtraining in endurance sports: a review.

Authors:  Cyril Petibois; Georges Cazorla; Jacques-Rémi Poortmans; Gérard Déléris
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 3.  Overtraining, excessive exercise, and altered immunity: is this a T helper-1 versus T helper-2 lymphocyte response?

Authors:  Lucille Lakier Smith
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 4.  Does overtraining exist? An analysis of overreaching and overtraining research.

Authors:  Shona L Halson; Asker E Jeukendrup
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 5.  Biochemical and immunological markers of over-training.

Authors:  Michael Gleeson
Journal:  J Sports Sci Med       Date:  2002-06-01       Impact factor: 2.988

6.  Monitoring for overreaching in rugby league players.

Authors:  Aaron J Coutts; Peter Reaburn; Terrence J Piva; Greg J Rowsell
Journal:  Eur J Appl Physiol       Date:  2007-01-12       Impact factor: 3.078

7.  Effects of military training on plasma amino acid concentrations and their associations with overreaching.

Authors:  Jenni N Ikonen; Raimo Joro; Arja Lt Uusitalo; Heikki Kyröläinen; Vuokko Kovanen; Mustafa Atalay; Minna M Tanskanen-Tervo
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-03

Review 8.  Diagnosis of overtraining: what tools do we have?

Authors:  Axel Urhausen; Wilfried Kindermann
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

9.  Psychomotor speed: possibly a new marker for overtraining syndrome.

Authors:  Esther Nederhof; Koen A P M Lemmink; Chris Visscher; Romain Meeusen; Theo Mulder
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

Review 10.  Biochemical aspects of overtraining in endurance sports : the metabolism alteration process syndrome.

Authors:  Cyril Petibois; Georges Cazorla; Jacques-Rémi Poortmans; Gérard Déléris
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.